Detained: Reducing Vulnerability in Prisons  TUAX03

Organiser:
Type:
Oral Abstract Session Back
Venue: SR 4 (550)
Interpretation: None
Time: 16:30 - 18:00, 05.08.2008
Code: TUAX03
Co-Chairs: Adeeba Kamarulzaman, Malaysia
Olivier Letouzé, Mexico




Presentations in this session:

16:30
TUAX0301
Introduction
Adeeba Kamarulzaman, Malaysia


16:35
TUAX0302
Abstract
Development of an educational intervention to reduce the risk of HIV/AIDS for incarcerated adolescents detained in a county jail
Presented by Sadie Sanders, United States
S. Sanders
University of Florida, Health Education and Behavior, Gainesville, United States


16:50
TUAX0303
Abstract
The harm inside: prevalence and correlates of injection during incarceration among injection drug users (IDUs) in Tijuana, Mexico
Presented by Robin A. Pollini, United States
R.A. Pollini1, J. Alvelais2, M. Gallardo2, A. Vera1, R. Lozada3, C. Magis-Rodriguez4, S.A. Strathdee1
1UCSD School of Medicine, La Jolla, United States, 2PrevenCasa, A.C., Tijuana, Mexico, 3Patronato Pro-COMUSIDA, Tijuana, Mexico, 4Centro Nacional para la Prevencion y Control del VIH/SIDA e ITS, Mexico City, Mexico


17:05
TUAX0304
Abstract
The social determinants of health and women offenders´ vulnerability to infection
Presented by Mary Beth Pongrac, Canada
M.B. Pongrac, J. Smith, B. Lajeunesse
Correctional Service of Canada, Ottawa, Canada


17:20
TUAX0305
Abstract
Substitution treatment in 3 Portuguese prisons
Presented by Maria Jose Campos, Portugal
M.J. Campos1, L. Fernandes2, J. Almeida1, L. Mendao1, R. Freitas1
1GAT-Grupo Portugues de Activistas sobre Tratamentos VIH/SIDA, Lisbon, Portugal, 2Faculdade de Psicologia e Ciencias da Educaçao - Universidade do Porto, Comportamento Desviante, Porto, Portugal


17:35
TUAX0306
Abstract
Antiretroviral therapy and HIV care in prison settings in Ukraine
Presented by Lyudmyla Kononenko, Ukraine
L. Kononenko, V. Lapshyna
Penitentiary Initiative, Nikolaev, Ukraine








Rapporteur report

Track E report by Alan Brotherton

This session identified a number of challenges in implementing effective HIV policies in relation to IDU and health care, within and outside jail.

The results of a prospective study of 1056 IDU in Tijuana, Mexico,  identified correlates of injection during incarceration. These included younger age, ever injecting a ‘speedball’, ever having sex with a man (among men) in jail; and ever having been arrested for needle or syringe possession. The latter is of particular concern as carrying injecting equipment without a prescription is not an offence in Mexico. Nonetheless,  31% of the sample had been arrested for carrying syringes. This highlights the deleterious effects on safe injecting behavior of poor implementation of policy on the part of arresting officers.  There is also an association between injecting in jail and subsequent unsafe ‘receptive’ injecting (ie using a syringe after another has used it) outside jail.

Other  presentations reflected the lack of equivalence in health care noted by Chuh (TUAX 01). A study of OST implementation in Portuguese prisons (Campos) found high levels of agreement among prison guards, HCW and inmates that introduction of OST had led to reduced violence and improved health of inmates. However, only one prison actively initiated OST and prison guards were reluctant to participate in the study and had generally poorer perceptions of improvements than HCW or inmates.  A study of access to ART in prisons in Ukraine identified prison guards’ attitudes and values as a barrier to timely access to ARV therapy for inmates, concluding that advocacy to address the shortfall in access to ARV for those who need it (117/200 in need, of 5074 HIV+ inmates nationally)and prison staff education were necessary to ensure adequate health care for HIV+ prisoners.




   

   

    The organizers reserve the right to amend the programme.


Copyright Notice © IAS Disclaimer